Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,380 across all filing types
Latest filing 2022-05-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
上海康德莱企业发展集团股份有限公司关于2020年限制性股票激励计划首次授予部分第二个解除限售期限制性股票解锁暨上市的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the unlocking and listing of restricted shares under the 2020 restricted stock incentive plan. It details the approval and implementation of the stock incentive plan, the conditions for lifting the lock-up period on the restricted shares, the number of shares unlocked, and the stock structure changes. It also includes legal opinions confirming compliance with relevant laws and regulations. The document is a formal announcement about the unlocking and listing of restricted shares, not a full financial report or management discussion. It is not an annual or interim report, earnings release, or management report. It is also not a proxy statement or voting result announcement. The content fits best with a Regulatory Filing (RNS) as it is a regulatory announcement about stock incentive plan execution and share unlocking, which does not fit other more specific categories.
2022-05-25 Chinese
关于上海康德莱企业发展集团股份有限公司不再将上海康德莱医疗器械股份有限公司纳入公司合并报表范围并构成重大资产重组的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding a significant change in the consolidation scope of its financial statements. It explains that Shanghai Kangdelai Medical Device Co., Ltd. will no longer be included in the company's consolidated financial statements due to loss of control over the subsidiary's board, which constitutes a major asset restructuring. The document includes background on shareholding, board changes, financial data of the subsidiary, and the impact on the parent company. It references accounting standards and regulatory rules about consolidation and major asset restructuring. The document is not a full annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about a major asset restructuring event, including financial data and implications. This fits best under the category of Capital/Financing Update (CAP), as it concerns a significant change in the company's capital structure and consolidation scope due to a major asset restructuring. The document length is 3419 characters, which is sufficient for a substantive announcement but not a full report. Therefore, the classification is CAP with high confidence.
2022-05-17 Chinese
上海康德莱企业发展集团股份有限公司关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the shareholding situation of the top ten shareholders and top ten unrestricted shareholders prior to a share repurchase plan. It references a board meeting approving a share repurchase plan and provides detailed shareholding data as of May 10, 2022. The content focuses on shareholding disclosures related to a share repurchase event, which aligns with reporting on transactions in own shares. The document length is short (1937 characters) and contains detailed shareholding data, not just a notice or link to a report. Therefore, it is not a report publication announcement or regulatory filing. The document fits best under the category of Transaction in Own Shares (POS), which covers company buyback or sale of its own shares disclosures.
2022-05-12 Chinese
上海康德莱企业发展集团股份有限公司关于以集中竞价交易方式回购公司股份的回购报告书
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding a share repurchase plan. It includes specifics about the repurchase purpose, scale, price, funding source, timeline, and risks. The document is not a financial report but a formal disclosure about the company's intention and plan to buy back its own shares for equity incentive purposes. It contains no financial statements or earnings data but focuses on the share repurchase program details, authorization, and regulatory compliance. This fits the definition of a Transaction in Own Shares (POS) filing, which covers announcements of share buybacks or sales by the company itself.
2022-05-12 Chinese
德恒上海律师事务所关于上海康德莱企业发展集团股份有限公司2021年年度股东大会之见证意见
Regulatory Filings
2022-05-11 Chinese
上海康德莱企业发展集团股份有限公司2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" for Shanghai Kangdelai Enterprise Development Group Co., Ltd. It details the date and method of the AGM, attendance, voting results on various proposals including financial reports, profit distribution, budget, and amendments to company rules. It also includes lawyer witness statements confirming the legality and validity of the meeting and resolutions. The content is focused on the official announcement of the voting results and resolutions passed at the AGM, rather than the full annual report or financial statements themselves. The document length is about 5800 characters, which is consistent with a detailed announcement rather than a full report. Therefore, this document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-05-11 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.